Skip to content

To know the efficacy of poly herbal compound in the management of irritable bowel syndrome

Clinical trial to evalute the efficacy of poly-herbal compound in the management of irritable bowel syndrome(IBS)

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038944
Enrollment
100
Registered
2021-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

None listed

Sponsors

Santanu pal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a. patients who are fulfilling the diagnostic criteria b.between the age group 18-70 years c. patient who are willing to participate

Exclusion criteria

Exclusion criteria: a. patients with severe complication of IBS b. serious health issue e.g-CA, diabetes mellitus,hypertention,stroke, HIV C. Subject with impaired renal function,impaired cardiac function,impaired hepatic function d. sign of systemic infection e. pregnant womens and lactating mothers

Design outcomes

Primary

MeasureTime frame
Decrease in sign and symptoms like pain, frequency and consistency of stoolTimepoint: 30 days

Secondary

MeasureTime frame
decrease in total scoringTimepoint: 30 days

Countries

India

Contacts

Public ContactDrBishnu prasad sarma

Govt ayurvedic College and hospital Guwahati

dr.bpsarma@gmail.com9864036018

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026